HomeNDC LookupRxCUI directory › RxCUI 596934

Duloxetine 60 MG Delayed Release Oral Capsule — RxCUI 596934

RxNorm drug concept · Semantic clinical drug
RxCUI 596934 Semantic clinical drug · SCD ● Current RxNorm concept 113 FDA products 316 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI596934
Official nameDuloxetine 60 MG Delayed Release Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asduloxetine 60 MG (as duloxetine HCl 67.3 MG) Delayed Release Oral Capsule
FDA products mapped113
Package NDCs mapped316
Reported Medicaid activity (SDUD)4,098,603 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Duloxetine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • You're right to ask — duloxetine does a lot more than treat depression. It's also approved for generalized anxiety disorder, diabetic nerve pain, fibromyalgia, and chronic musculos...
  • What is duloxetine actually used for? My doctor prescribed it but I wasn't sure it was just for depression.
  • It depends on which product you have. Most duloxetine delayed-release capsules — including Cymbalta — must be swallowed whole. Crushing, chewing, or opening them damages the specia...
  • Can I open the capsule or crush it if I have trouble swallowing pills?
📖 Read our full Duloxetine guide →

🕸️ Concept Web — How Duloxetine 60 MG Delayed Release Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Duloxetine 60 MG Delayed Release Oral Capsule RxCUI 596934

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Duloxetine 72625
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Cymbalta 482574
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Duloxetine Delayed Release Oral Capsule 540628
    • Duloxetine Oral Product 1161267
    • Duloxetine Pill 1161268
    • Duloxetine Delayed Release Oral Capsule [Cymbalta] 540631
    • Cymbalta Oral Product 1174445
    • Cymbalta Pill 1174446
    • Delayed Release Oral Capsule 316995
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Duloxetine 60 MG SCDC · 596933
  • Duloxetine Delayed Release Oral Capsule SCDF · 540628
  • Duloxetine Oral Product SCDG · 1161267
  • Duloxetine Pill SCDG · 1161268

Brand-Name Concepts

📦 FDA Products & Package NDCs

113 products · 316 package NDCs
316 package NDCs map to RxCUI 596934 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
80425-0119-02 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0119-2) Duloxetine DR Advanced Rx Pharmacy of Tennessee, LLC 2017-03-16
80425-0119-03 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0119-3) Duloxetine DR Advanced Rx Pharmacy of Tennessee, LLC 2023-03-30
80425-0389-01 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0389-1) Duloxetine Advanced Rx of Tennessee, LLC 2024-05-22
80425-0389-02 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0389-2) Duloxetine Advanced Rx of Tennessee, LLC 2024-05-22
80425-0389-03 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0389-3) Duloxetine Advanced Rx of Tennessee, LLC 2024-05-22
80425-0441-01 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0441-1) Duloxetine Advanced Rx of Tennessee, LLC 2024-10-22
80425-0441-02 60 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0441-2) Duloxetine Advanced Rx of Tennessee, LLC 2024-10-22
80425-0441-03 90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (80425-0441-3) Duloxetine Advanced Rx of Tennessee, LLC 2024-10-22
82009-0029-05 500 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-029-... Duloxetine Quallent Pharmaceuticals Health, LLC 2022-12-15
82009-0030-10 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-030... Duloxetine Quallent Pharmaceuticals Health, LLC 2022-12-15
82009-0031-90 90 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-031-9... Duloxetine Quallent Pharmaceuticals Health, LLC 2023-06-01
82009-0032-10 1000 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (82009-032... Duloxetine Quallent Pharmaceuticals Health, LLC 2022-12-15
82009-0170-10 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-170-10) Duloxetine Quallent Pharmaceuticals Health LLC 2025-07-01
82009-0171-10 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-171-10) Duloxetine Quallent Pharmaceuticals Health LLC 2025-07-01
82009-0172-30 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-172-30) Duloxetine Quallent Pharmaceuticals Health LLC 2025-07-01
82009-0173-10 1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (82009-173-10) Duloxetine Quallent Pharmaceuticals Health LLC 2025-07-01
Observed labelers: Bryant Ranch Prepack (26) · Asclemed USA, Inc. (23) · Camber Pharmaceuticals, Inc. (19) · Sun Pharmaceutical Industries, Inc. (17) · Inventia Healthcare Limited. (15) · Ascend Laboratories, LLC (13) · +35 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.